A 2026 interview and a major JAMA cohort study link moderate coffee intake to a lower risk of dementia, though experts advise maintaining balanced habits.
On September 21, 2026, the publication Ara.cat published an interview with neuroscientist John Cryan discussing recent epidemiological findings that link moderate coffee consumption to a lower risk of developing dementia. The interview took place after his visit to Barcelona for a biomedical research symposium at Pompeu Fabra University.
Cryan is a professor and director of the Department of Anatomy and Neuroscience at University College Cork. His research includes gut and brain communication and how dietary habits influence long-term neurological health. During his interview, he explained that large epidemiological studies associate moderate coffee consumption with a lower likelihood of developing dementia. Specifically, drinking approximately two or three cups daily correlates with less cognitive impairment in later life.
The strongest directly relevant evidence comes from a large prospective cohort study published in JAMA. Researchers analyzed data from 131,821 participants across the Nurses' Health Study and the Health Professionals Follow-up Study. They followed these individuals for as long as 43 years to track changes in their cognitive health. The combined cohorts included 86,606 women and 45,215 men, and the research featured a median follow-up period of 36.8 years.
Over this extensive follow-up period, the researchers recorded 11,033 incident dementia cases among the participants. The team compared the highest and lowest quartiles of caffeinated coffee consumption to understand the risk differences. In the highest consumption group, the dementia incidence was 141 cases per 100,000 person-years. This compared favorably to 330 cases per 100,000 person-years for those with the lowest intake.
This significant difference in incidence corresponds to a hazard ratio of 0.82. This ratio represents approximately an 18 percent lower relative risk for the highest consumers of caffeinated coffee. The researchers also conducted a detailed dose and response analysis to find the optimal intake levels. They found the lowest estimated dementia risk occurred at approximately two to three cups of caffeinated coffee per day.
This protective threshold equals roughly 300 milligrams of caffeine daily. The data showed that higher intake did not produce a clearly greater benefit for cognitive health. Beyond clinical dementia diagnoses, caffeinated coffee consumption was also associated with a lower prevalence of subjective cognitive decline. The prevalence was 7.8 percent in the highest coffee consumption quartile, compared to 9.5 percent in the lowest quartile.
The JAMA study also examined tea consumption and found broadly similar protective associations. Participants in the highest tea consumption tertile had a dementia hazard ratio of 0.86 compared with the lowest tertile. This hazard ratio equates to an approximately 14 percent lower relative risk for heavy tea drinkers. For tea, the lowest risk estimates occurred at around one to two cups per day.
The researchers also analyzed specific genetic factors related to cognitive decline and dementia risk. They found that the associations did not materially differ according to APOE4 genotype or Alzheimer disease polygenic risk score. This observation suggests the relationship between coffee and brain health holds across different genetic profiles. However, this finding does not mean that drinking coffee eliminates inherited dementia risk.
Finding reliable dementia and cognitive protection resources remains vital for older adults navigating genetic risk factors. These resources provide context for interpreting population studies alongside personal family histories.
If an older adult already enjoys coffee and tolerates it well, continuing the habit makes sense. Two to three ordinary cups a day is the intake range most consistently associated with favorable dementia risk estimates. Older adults should view this range as an observed statistical association rather than a strict medical treatment target. People who do not drink coffee do not need to begin drinking it to protect their memory.
The research does not demonstrate that starting a new coffee habit actively prevents dementia in older adults. Any potential cognitive benefits must be carefully weighed against personal tolerance and existing medical circumstances. Cryan emphasized that coffee is chemically complex and contains hundreds of distinct compounds. It includes beneficial polyphenols and is not simply a delivery system for caffeine.
Cryan described a small study involving 62 Irish adults aged 30 to 50 to illustrate this chemical complexity. The study included 31 regular coffee consumers and 31 individuals who did not drink coffee. Researchers observed that coffee abstinence was followed by changes in microbiota, immune markers and anxiety levels. The study reported that these markers normalized after the participants reintroduced coffee into their diets.
Cryan explicitly stated that this study was small and requires much more research before drawing clinical conclusions. The small study also reported different associations for caffeinated and decaffeinated coffee. Decaffeinated coffee was linked with some learning and memory outcomes in the research findings. Caffeinated coffee was linked with specific attention and anxiety outcomes.
Both types of coffee were associated with lower stress, depressive symptoms and inflammation in the study's reported findings. Older adults seeking information on nutrition and brain performance should treat these results as preliminary scientific observations. They are not established clinical effects that justify drastic dietary changes.
Coffee should ultimately sit within a much broader and comprehensive brain health pattern. This comprehensive pattern should include regular physical activity, a nutrient-dense diet, adequate sleep and strong social connection. It also requires the appropriate clinical management of cardiovascular risk factors over time. The interview itself does not provide a quantified combined lifestyle protocol for older adults to follow.
Instead, these daily habits provide general context for maintaining cognitive health as we age. Relying on a single beverage cannot replace the cumulative benefits of a well-rounded routine. Integrating these varied elements effectively requires a focus on sustainable lifestyle and brain resilience over time.
The JAMA findings provide valuable insights, but they do not establish that coffee actively prevents dementia. The study was observational in its design, which limits the conclusions researchers can draw. Residual confounding, reverse causation and other differences between coffee drinkers and non-drinkers remain possible explanations. The phrase "lower risk" represents a relative association rather than a guarantee that an individual will avoid cognitive impairment.
Individuals should not increase their coffee intake beyond a personally comfortable amount in pursuit of greater protection. The available dose and response evidence does not show a clear added advantage at higher intake levels. Furthermore, the modest nature of the objective cognitive results highlights the need for careful interpretation. Researchers tested 17,139 women over age 70 in the Nurses' Health Study for objective cognitive function.
They found that the highest versus lowest quartile of caffeinated coffee intake was associated with a 0.11-point higher test score. Meanwhile, the association with a broader global cognition score was not statistically significant. Objective cognitive testing was available only in the Nurses' Health Study and not the Health Professionals Follow-up Study. The study did not establish that these modest test differences translate into noticeable improvements in daily independence.
Participant demographics also limit how broadly the medical community can apply these findings. The study participants were predominantly health professionals from two distinct U.S. cohorts. Each cohort represented one sex, which means the findings may not generalize equally to every older adult population. Additionally, dementia ascertainment relied on death records, self-reported physician diagnoses and medical-record confirmation when available.
This ascertainment methodology means some misclassification of dementia cases is possible within the study data. Cryan specifically cautioned that caffeine can increase blood pressure and acts as a central nervous system stimulant. An amount associated with lower dementia risk in population studies may not be medically appropriate for every individual. The study literature notes that excessive caffeine consumption may actually worsen sleep quality or baseline anxiety.
Older adults experiencing hypertension, palpitations or anxiety should proceed with caution. Those dealing with insomnia, medication interactions or caffeine sensitivity must also moderate their intake. They should not increase their coffee consumption solely because of an observational epidemiological association. Finally, the apparent lack of benefit for decaffeinated coffee should not be interpreted as proof that decaf is harmful.
Researchers noted that people frequently choose decaf because of caffeine intolerance or existing health concerns. This pattern creates possible statistical confusion within the study results. The study also did not capture every specific detail that could influence individual health outcomes. It lacked data on coffee preparation methods, bean origin, roast level or preferred brewing techniques.
The current epidemiological research provides an encouraging perspective on a very common daily habit. While moderate coffee consumption is consistently linked to a lower risk of cognitive decline, it is not a cure. The data supports enjoying a few cups a day if you tolerate caffeine well. However, it does not support using coffee to offset poor overall health habits or a sedentary lifestyle.
Protecting long-term cognitive capability requires consistent attention to sleep, daily physical movement and sustained mental engagement. Older adults can confidently maintain their morning coffee routines without assuming it serves as an absolute medical shield. The most responsible approach respects personal physical reactions to caffeine while appreciating coffee as a cultural pleasure. Staying informed through reliable brain aging and neuroplasticity articles helps you place individual dietary studies into their proper perspective.
Independent older adults and their healthcare teams frequently manage conflicting advice about nutrition, exercise, sleep, supplements and brain performance. FitBrainLab evaluates complex epidemiological studies on dietary habits to help you separate established findings from early scientific observations. This clear editorial analysis allows you to organize a sustainable daily routine without relying on sensational medical claims. Explore Resources
Follow FitBrainLab for research-led insights on memory, focus, brain aging, nutrition and mental fitness after 60. Stay connected for new articles, practical guidance and ideas for a sharper, more engaged life.
Build habits that support memory, focus and a curious, connected life.
Read the Blog
